Norepinephrine, when administered to normotensive subjects by continuous intravenous infusion produces a marked renal vasoconstriction and a reduction in renal blood flow. The opposite response is observed when this drug is given to patients in whom glomerular filtration Irate and renal blood flow are already depressed due to shock. W~lhen the blood pressure in these patients is returned to normal with norepinephrine, there is an increase in both glomerular filtration rate and renal blood flow. There is also an increase in water and electrolyte excretion which is secondary to the increase in glomerular filtration rate.
ALTHOUGH vasopressor agents have been advocated for the treatment of shock, very few observations have been made on the hemodynamic responses of critical vascular beds to these compounds. Recently we have observed that when patients are made hypotensive with ganglionic blocking agents, blood flow through the kidneys and brain is reduced.", 2 When these same subjects are then rendered normotensive with vasopressor agents, the blood flow to these organs rapidly approaches the control observations.2 3 Although not analogous to shock, these observations present a paradox since if vasopressor agents are administered to normal subjects and the blood pressure raised to hypertensive levels, blood flow through the kidneys is reduced. 4 These apparently confusing observations suggest a need for a better understanding of the pharmacodynamics of vasopressor agents when used either as primary treatment of hypotension or as an adjunct to other measures used in the treatment of shock. The current observations were made in order to assess the renal functional response to vasopressor agents when used for the treatment of shock due to numerous causes. 
MATERIAL AND MIETHOI)S
The patients in this study are divided into two groups. The first group was composed of patients admitted to the emergency room of a city-county hospital with untreated hemorrhagic and traumatic shock for which thev received norepinephrine or Aramine (levo 1-(m-hydroxyphenyl1)-2-amino-1-propanol). The second group consisted of hospitalized patients who received a vasopressor agent for the treatment of normovolemic shock due to numerous causes.
Renal function was determined, using inulin clearance as a measure of glomerular filtration rate (GFR) and low concentrations (2 to 4 mg. per 100 cc.) of para-aminohippurate (PAH) to measure renal plasma flow, methods and techniques previouslv described being used.5 ' 6 In the normovolemic group who were already being treated with a continuous infusion of norepinephrine, the norepinephrine was discontinued long enough to obtain two or three 10-minute collection periods during hypotension. These were designated as the control observations. Norepinephrine infusion was then restarted and a variable number of additional 10-minute collection periods obtained.
In the hemorrhagic and traumatic cases, 1,000 to 1,500 cc. of 5 per cent glucose in water were given rapi(lly (intravenously) on arrival in the emergency room in order to insure satisfactory hydration for maximum urine formation under the circumstances. One to three 10-minute collection periods were then obtained while the patient was in shock. Patients During shock due to hemorrhage and other causes, urine volume and the excretion rates of sodium and potassium were markedly depressed. As the blood pressure was increased there was a sharp increase in both water and sodium excretion. This was probably a reflection of the increase in glomerular filtration rate. Even in the patient with tubular necrosis, there was an increase in sodium and water excretion even though glomerular filtration rate did not increase above 30 cc. per minute which is about one-fourth of the normal value. In the patients with shock due to hemorrhage, blood transfusions appeared to increase sodium excretion more than norepinephrine did. There was usually a parallel increase in potassium excretion.
CASE REPORTS
The following cases are given in more detail because they present pertinent points in the study. As the glomerular filtration rate increased with both the vasopressor agent and the blood transfusion, there was a sharp increase in urine volume ( fig. 1B) . This was associated with a moderate initial and sustained increase in sodium and potassium excretion. The increase in sodium excretion was more marked after blood replacement than after blood pressure elevation with the vasopressor agent. fig. 7) .
Clinical Observations. The effect of vasopressor agents on the human kidney in the normotensive subject is quite similar to that observed in the laboratory animal. As the blood pressure increases renal blood flow is first reduced. If the rate of infusion is great enough, glomerular filtration rate may also be reduced (table 5) . However, the renal hemodynamic response to vasopressor agents in the presence of shock is entirely different than when these agents are administered to normal subjects. In the shocked patient there exists a marked reduction in renal blood flow and glomerular filtration rate which is due to a combination of renal vasoconstriction and hypotension (tables 2 and 3). When the blood pressure is now increased with a vasopressor agent, some of the renal vasoconstrictor response is relieved and the intraglomerular filtration pressure increases. As a result, renal blood flow, glomerular filtration rate, and urine output are increased.
When glomerular filtration rates before and after treatment with vasopressor agents or blood transfusions are plotted (graphed) against blood pressure in the hemorrhagic shock patients (group I), one can see that the degree of increase in glomerular filtration rate after blood replacement is well interspersed with the response to vasopressor agents, indicating very minor differences, if any, in the overall response. When glomerular filtration rate is plotted against urine volume after blood pressure elevation with either vasopressor agents or blood transfusions, one observes that although urine volume increases, the increase in glomerular filtration rate appears to be the primary response. Although the control values for renal function are not considered as quantitative estimations, these observations certainly indicate directional changes following the administration of vasopressor agents and blood since the observations made after blood pressure elevation can be considered more or less accurate because urine volume was quite adequate at this time.
In mild to moderate hemorrhagic shock, blood transfusions do not appear to be superior to vasopressor agents for increasing glomerular filtration rate and renal blood flow (table 2). The increase in blood pressure frequently does not have to be very great in order to produce a rather sharp increase in glomerular filtration rate. If blood loss is too great and very large amounts of norepinephrine are required to raise the blood pressure, improvement in renal function is not observed after the administration of vasopressor agents. However, if part of the normal blood volume is replaced, norepinephrine now produces a significant improvement in renal function ( fig. 8) These responses to vasopressor agents speaks against a humoral agent being responsible for the renal vasoconstriction associated with hemorrhagic shock in man, especially since glomerular filtration rate and renal blood flow return to normal ranges. If a circulating agent were responsible for the renal vasoconstriction which occurs in shock, one would not anticipate that the administration of a second vasoconstrictor would relieve the vascular constriction produced by the first. It is possible, however, but not likely, that norepinephrine directly antagonizes circulating vasoconstrictor substances which are liberated by the patient in shock.
In the patients with normovolemic shock there is a consistent increase in renal blood flow and glomerular filtration rate but they never approach normal ranges. Even though the increase in glomerular filtration rate is not great, there is a rather consistent increase in urine volume and electrolyte excretion.
SUMMARY AND CONCLUSIONS (1) Renal function studies have been made in patients suffering with clinical shock due to various etiologies. Renal function was determined during shock, during norepinephrineinduced normotension, and in traumatic cases, after blood volume replacement.
(2) Although norepinephrine administration to normotensive human subjects increases renal vascular resistance and depresses renal blood flow, when administered to patients who are in shock the opposite effect results. This ambivalent action of norepinephrine is thought to result from a differential vasoconstriction between the kidney and the remainder of the general circulatory bed. The elevation in blood pressure incident to the administration of norepinephrine to patients in shock is due to an overall increase in peripheral vascular resistance but the lesser renal vasoconstrictor effect results in an increase in renal blood flow and glomerular filtration rate with an actual reduction in renal vascular resistance.
(3) Norepinephrine improves renal function
